top of page

UGD381

Urinary and reproductive system disease tissue array, 38 cases of normal, inflammatory and neoplastic conditions of multiple urinary/genital organs

Specifications

Price per slide: 

$201

Species:

Human

Cases:

38

Cores:

38

Core Size:

2.0mm

Core Thickness:

4um

Rows:

5

Columns:

8

Format:

Intended Usage:

For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in common diseases of the urinary and reproductive system.

6x9.jpg

5

X

8

For illustration purpose only.  Actual product may vary.

Notes:

All the tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or APES coated Superfrost slides. They can be stored for use at 4C for up to six months from the date of shipment. There may be 5 to 10% of tissue core loss.

Bake at 60C for ~60 minutes before use. If antigen retrieving is needed, it is important to avoid direct-boiling and high pH or high strength antigen retrieving buffer. For availability of complimentary IHC data, please contact us at info@pantomics.com.

1
2
3
4
5
6
7
8
A
B
C
D
E
A01
B01
C01
D01
E01
A02
B02
C02
D02
E02
Work Desk
Work Desk
Work Desk
Work Desk
Work Desk
A04
B04
C04
D04
E04
A05
B05
C05
D05
E05
Work Desk
Work Desk
Work Desk
Work Desk
Work Desk
Work Desk
Work Desk
Work Desk
Work Desk
Work Desk
Work Desk
Work Desk
Work Desk
ARRAY POSITION
IMAGE
SEX
AGE
ANATOMIC SITE
PATHOLOGY
NATURE
GRADE
STAGE (TNM)
A01
F
51
Kidney
Renal cortex
Normal
A02
F
51
Kidney
Normal kidney medulla
Normal
A03
F
44
Kidney
Chronic pyelonephritis
Inflammatory
A04
M
48
Kidney
Renal atrophy
Benign
A05
F
63
Kidney
Tuberculosis, TB granuloma
Benign
A06
F
71
Kidney
Clear cell carcinoma
Malignant
T1N0M0
A07
M
43
Kidney
Clear cell carcinoma
Malignant
T2N0M0
A08
F
72
Kidney
Papillary renal cell carcinoma
Malignant
T1N0M0
B01
F
65
Bladder, urinary
Normal bladder
Normal
B02
F
53
Bladder, urinary
Transitional cell cacinoma
Malignant
I~II
T1N0M0
B03
M
61
Bladder, urinary
Transitional cell cacinoma
Malignant
III
T3N0M0
B04
M
64
Prostate
Normal, hyperplasia
Normal
B05
M
76
Prostate
Hyperplasia
Hyperplasia
B06
M
68
Prostate
Hyperplasia
Hyperplasia
B07
M
60
Prostate
Adenocarcinoma
Malignant
II
T2N0M0
B08
M
63
Prostate
Adenocarcinoma
Malignant
III
T3N0M0
C01
M
34
Skin, penis
Squamous cell carcinoma
Malignant
I
T1N0M0
C02
M
69
Testis
Normal testis
Normal
C03
M
30
Testis
Seminoma
Malignant
C04
M
36
Testis
Seminoma
Malignant
T2N0M0
C05
F
40
Ovary
Normal ovary
Normal
C06
F
34
Ovary
Serous cystadenocarcinoma
Malignant
I
T2N0M0
C07
F
58
Ovary
Endometrioid adenocarcinoma
Malignant
III
T2N0M0
C08
F
45
Ovary
Adenocarcinoma
Malignant
T2N0M0
D01
F
31
Ovary
Teratoma
Benign
D02
F
56
Uterus, cervix
Normal cervix
Normal
D03
F
33
Uterus, cervix
Polyps
Benign
D04
F
41
Uterus, cervix
Squamous cell carcinoma
Malignant
I~II
T1N1M0
D05
F
63
Uterus, cervix
Squamous cell carcinoma
Malignant
II
T1N0M0
D06
F
31
Uterus, cervix
Squamous cell carcinoma
Malignant
II~III
T2N0M0
D07
F
35
Uterus, endometrium
Normal endometrium
Benign
D08
F
59
Uterus, endometrium
Adenocarcinoma
Malignant
I~II
T1N0M0
E01
F
49
Uterus, endometrium
Adenocarcinoma
Malignant
I
T3N1M0
E02
F
78
Uterus, endometrium
Adenocarcinoma
Malignant
II
T2N1M0
E03
F
42
Uterus, myometrium
Normal myometrium
Normal
E04
F
38
Uterus, myometrium
Leiomyoma
Benign
E05
F
52
Uterus, myometrium
Leiomyosarcoma
Malignant
E06
F
39
Skin, vulva
Squamous cell carcinoma
Malignant
II
T1N0M0
bottom of page